Strategies to strike survival networks in cancer

Marzia Pennati, Graziella Cimino-Reale, Laura Gatti Laura, Giuliana Cassinelli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The machinery that maintains cellular and tissue homeostasis in a healthy individual is recruited and hijacked by cancer cells to support tumor growth and progression. Activation of often unpredictable alternative or complementary signaling pathways allows cancer cells to bypass the intrinsic self-destructive machinery and the limited replicative potential present in every cell for correct homeostasis maintenance. Therefore, evasion/resistance to apoptosis/cell death, self-sufficiency in growth/survival signals, and limitless replicative potential remain undoubted hallmarks of cancer, contributing to drug resistance. Herein, we specifically review antitumor strategies involving agents targeting deregulated receptor tyrosine kinases, selected epigenetic modifications, the ubiquitin-proteasome system, the unfolded protein response, the apoptotic pathway, and peculiar nucleic acid structures, with the aim of highlighting the mechanisms underlying favorable drug interaction. In this context, we focus on preclinical studies that have already been translated into clinical investigation. Particular emphasis is devoted to strategies effective in solid tumors because of the peculiarity and distinctive features of solid tumors in terms of drug delivery and relative to the impact of the tumor microenvironment.

Original languageEnglish
Pages (from-to)269-308
Number of pages40
JournalCritical Reviews in Oncogenesis
Volume21
Issue number3-4
DOIs
Publication statusPublished - 2016

Fingerprint

Neoplasms
Homeostasis
Unfolded Protein Response
Tumor Microenvironment
Receptor Protein-Tyrosine Kinases
Proteasome Endopeptidase Complex
Growth
Ubiquitin
Drug Interactions
Drug Resistance
Epigenomics
Nucleic Acids
Cell Death
Maintenance
Apoptosis
Pharmaceutical Preparations

Keywords

  • Apoptosis
  • Drug resistance
  • Epigenetics
  • G-quadruplex
  • Nucleic acids
  • Oncogene promoters
  • Receptor tyrosine kinases
  • Survival pathways
  • Ubiquitin-proteasome
  • Unfolded protein response

ASJC Scopus subject areas

  • Medicine(all)
  • Cancer Research

Cite this

Pennati, M., Cimino-Reale, G., Laura, L. G., & Cassinelli, G. (2016). Strategies to strike survival networks in cancer. Critical Reviews in Oncogenesis, 21(3-4), 269-308. https://doi.org/10.1615/CritRevOncog.2016016966

Strategies to strike survival networks in cancer. / Pennati, Marzia; Cimino-Reale, Graziella; Laura, Laura Gatti; Cassinelli, Giuliana.

In: Critical Reviews in Oncogenesis, Vol. 21, No. 3-4, 2016, p. 269-308.

Research output: Contribution to journalArticle

Pennati, M, Cimino-Reale, G, Laura, LG & Cassinelli, G 2016, 'Strategies to strike survival networks in cancer', Critical Reviews in Oncogenesis, vol. 21, no. 3-4, pp. 269-308. https://doi.org/10.1615/CritRevOncog.2016016966
Pennati, Marzia ; Cimino-Reale, Graziella ; Laura, Laura Gatti ; Cassinelli, Giuliana. / Strategies to strike survival networks in cancer. In: Critical Reviews in Oncogenesis. 2016 ; Vol. 21, No. 3-4. pp. 269-308.
@article{dfbc03fbfdb34c588246d69f4fe5a041,
title = "Strategies to strike survival networks in cancer",
abstract = "The machinery that maintains cellular and tissue homeostasis in a healthy individual is recruited and hijacked by cancer cells to support tumor growth and progression. Activation of often unpredictable alternative or complementary signaling pathways allows cancer cells to bypass the intrinsic self-destructive machinery and the limited replicative potential present in every cell for correct homeostasis maintenance. Therefore, evasion/resistance to apoptosis/cell death, self-sufficiency in growth/survival signals, and limitless replicative potential remain undoubted hallmarks of cancer, contributing to drug resistance. Herein, we specifically review antitumor strategies involving agents targeting deregulated receptor tyrosine kinases, selected epigenetic modifications, the ubiquitin-proteasome system, the unfolded protein response, the apoptotic pathway, and peculiar nucleic acid structures, with the aim of highlighting the mechanisms underlying favorable drug interaction. In this context, we focus on preclinical studies that have already been translated into clinical investigation. Particular emphasis is devoted to strategies effective in solid tumors because of the peculiarity and distinctive features of solid tumors in terms of drug delivery and relative to the impact of the tumor microenvironment.",
keywords = "Apoptosis, Drug resistance, Epigenetics, G-quadruplex, Nucleic acids, Oncogene promoters, Receptor tyrosine kinases, Survival pathways, Ubiquitin-proteasome, Unfolded protein response",
author = "Marzia Pennati and Graziella Cimino-Reale and Laura, {Laura Gatti} and Giuliana Cassinelli",
year = "2016",
doi = "10.1615/CritRevOncog.2016016966",
language = "English",
volume = "21",
pages = "269--308",
journal = "Critical Reviews in Oncogenesis",
issn = "0893-9675",
publisher = "Begell House Inc.",
number = "3-4",

}

TY - JOUR

T1 - Strategies to strike survival networks in cancer

AU - Pennati, Marzia

AU - Cimino-Reale, Graziella

AU - Laura, Laura Gatti

AU - Cassinelli, Giuliana

PY - 2016

Y1 - 2016

N2 - The machinery that maintains cellular and tissue homeostasis in a healthy individual is recruited and hijacked by cancer cells to support tumor growth and progression. Activation of often unpredictable alternative or complementary signaling pathways allows cancer cells to bypass the intrinsic self-destructive machinery and the limited replicative potential present in every cell for correct homeostasis maintenance. Therefore, evasion/resistance to apoptosis/cell death, self-sufficiency in growth/survival signals, and limitless replicative potential remain undoubted hallmarks of cancer, contributing to drug resistance. Herein, we specifically review antitumor strategies involving agents targeting deregulated receptor tyrosine kinases, selected epigenetic modifications, the ubiquitin-proteasome system, the unfolded protein response, the apoptotic pathway, and peculiar nucleic acid structures, with the aim of highlighting the mechanisms underlying favorable drug interaction. In this context, we focus on preclinical studies that have already been translated into clinical investigation. Particular emphasis is devoted to strategies effective in solid tumors because of the peculiarity and distinctive features of solid tumors in terms of drug delivery and relative to the impact of the tumor microenvironment.

AB - The machinery that maintains cellular and tissue homeostasis in a healthy individual is recruited and hijacked by cancer cells to support tumor growth and progression. Activation of often unpredictable alternative or complementary signaling pathways allows cancer cells to bypass the intrinsic self-destructive machinery and the limited replicative potential present in every cell for correct homeostasis maintenance. Therefore, evasion/resistance to apoptosis/cell death, self-sufficiency in growth/survival signals, and limitless replicative potential remain undoubted hallmarks of cancer, contributing to drug resistance. Herein, we specifically review antitumor strategies involving agents targeting deregulated receptor tyrosine kinases, selected epigenetic modifications, the ubiquitin-proteasome system, the unfolded protein response, the apoptotic pathway, and peculiar nucleic acid structures, with the aim of highlighting the mechanisms underlying favorable drug interaction. In this context, we focus on preclinical studies that have already been translated into clinical investigation. Particular emphasis is devoted to strategies effective in solid tumors because of the peculiarity and distinctive features of solid tumors in terms of drug delivery and relative to the impact of the tumor microenvironment.

KW - Apoptosis

KW - Drug resistance

KW - Epigenetics

KW - G-quadruplex

KW - Nucleic acids

KW - Oncogene promoters

KW - Receptor tyrosine kinases

KW - Survival pathways

KW - Ubiquitin-proteasome

KW - Unfolded protein response

UR - http://www.scopus.com/inward/record.url?scp=84992520612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992520612&partnerID=8YFLogxK

U2 - 10.1615/CritRevOncog.2016016966

DO - 10.1615/CritRevOncog.2016016966

M3 - Article

AN - SCOPUS:84992520612

VL - 21

SP - 269

EP - 308

JO - Critical Reviews in Oncogenesis

JF - Critical Reviews in Oncogenesis

SN - 0893-9675

IS - 3-4

ER -